Safety and Effect of Liraglutide in Patients With Type 2 Diabetes and Severe Renal Insufficiency.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History